Sommerhauser G, Kurreck A, Stintzing S, Heinemann V, et al. Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line BMC Cancer 2022;22:820.
PMID: 35897060